A randomized, controlled phase III global trial comparing sipuleucel‑T plus androgen deprivation therapy versus androgen deprivation therapy alone in men with metastatic androgen dependent (hormone sensitive) prostate cancer.
K. Fizazi
Consultant or Advisory Role - Dendreon (I,U)
T. Powles
Consultant or Advisory Role - Dendreon (I)
D. J. George
Consultant or Advisory Role - Dendreon
Honoraria - Dendreon
Research Funding - Dendreon
C. H. Poehlein
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon